Related Experiment Videos

Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early

Shin-ichi Kawachi1, Noriyuki Takeda, Akihiko Sasaki

  • 1Department of Diabetes and Endocrinology, Medical Sciences Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan. kawachi@cc.gifu-u.ac.jp

Insights

Increased levels of insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) are linked to early carotid atherosclerosis in Japanese men. These factors may promote the development of atherosclerosis.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Syndrome

Background:

  • The growth hormone (GH)-insulin-like growth factor (IGF)-1 axis influences vascular and cardiac cell function.
  • The precise role of the GH-IGF-1 axis in cardiovascular disease remains debated.

Purpose of the Study:

  • To investigate the association between circulating levels of IGF-1 and IGFBP-3 with early carotid atherosclerosis.
  • To examine the relationship of IGF-1 and IGFBP-3 with traditional atherosclerotic risk factors.

Main Methods:

  • Cross-sectional study of 330 Japanese men.
  • Measurement of carotid intima-media thickness (IMT) via ultrasound.
  • Assessment of abdominal adipose tissue (visceral and subcutaneous) using computed tomography.
  • Partial correlation analysis to determine associations.

Main Results:

  • Circulating IGF-1 and IGFBP-3 levels were positively associated with body mass index and plasma insulin.
  • IGF-1 correlated with subcutaneous adipose tissue and inversely with high-density lipoprotein cholesterol.
  • IGFBP-3 showed positive associations with blood pressure, total cholesterol, and visceral adipose tissue.
  • Both IGF-1 and IGFBP-3 were independently associated with carotid IMT, suggesting a direct role in atherosclerosis development.

Conclusions:

  • Elevated circulating IGF-1 and IGFBP-3 may act as accelerators of atherosclerosis.
  • These findings contribute to understanding the complex role of the GH-IGF-1 axis in cardiovascular pathology.
Abstract